NORA KURBAJ: Open Payments
NPI 1831716976 · BEVERLY, MA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,122 in 56 payments from 11 companies in 2025. Trend: 2023 $896 · 2024 $1,114 · 2025 $1,122
Food & beverage: $1,122
| Company | Payments | Amount |
|---|---|---|
| TOLMAR, INC. | 17 | $319 |
| Endo USA, Inc. | 10 | $193 |
| Antares Pharma, Inc. | 7 | $162 |
| Novo Nordisk Inc | 7 | $139 |
| Azurity Pharmaceuticals, Inc. | 5 | $86 |
| Amgen Inc. | 3 | $64 |
| Alnylam Pharmaceuticals Inc. | 2 | $46 |
| Lilly USA, LLC | 2 | $45 |
| ABBVIE INC. | 1 | $26 |
| MEDICOMP INC | 1 | $22 |
Products named: JATENZO, AVEED, XYOSTED, Wegovy, AZMIRO, REPATHA, AMVUTTRA, MOUNJARO.
Industry payments across MA — which companies pay providers there.
